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The RGD motif in the Severe Acute Syndrome Coronavirus 2 (SARS-CoV-2) spike protein
has been predicted to bind RGD-recognizing integrins. Recent studies have shown that
the spike protein does, indeed, interact with aVb3 and a5b1 integrins, both of which bind to
RGD-containing ligands. However, computational studies have suggested that binding
between the spike RGD motif and integrins is not favourable, even when unfolding occurs
after conformational changes induced by binding to the canonical host entry receptor,
angiotensin-converting enzyme 2 (ACE2). Furthermore, non-RGD-binding integrins, such
as ax, have been suggested to interact with the SARS-CoV-2 spike protein. Other viral
pathogens, such as rotaviruses, have been recorded to bind integrins in an RGD-
independent manner to initiate host cell entry. Thus, in order to consider the potential
for the SARS-CoV-2 spike protein to bind integrins independent of the RGD sequence, we
investigate several factors related to the involvement of integrins in SARS-CoV-2 infection.
First, we review changes in integrin expression during SARS-CoV-2 infection to identify
which integrins might be of interest. Then, all known non-RGD integrin-binding motifs are
collected and mapped to the spike protein receptor-binding domain and analyzed for their
3D availability. Several integrin-binding motifs are shown to exhibit high sequence
similarity with solvent accessible regions of the spike receptor-binding domain.
Comparisons of these motifs with other betacoronavirus spike proteins, such as SARS-
CoV and RaTG13, reveal that some have recently evolved while others are more
conserved throughout phylogenetically similar betacoronaviruses. Interestingly, all of the
potential integrin-binding motifs, including the RGD sequence, are conserved in one of
the known pangolin coronavirus strains. Of note, the most recently recorded mutations in
the spike protein receptor-binding domain were found outside of the putative
integrin-binding sequences, although several mutations formed inside and close to one
motif, in particular, may potentially enhance binding. These data suggest that the SARS-
CoV-2 spike protein may interact with integrins independent of the RGD sequence and
may help further explain how SARS-CoV-2 and other viruses can evolve to bind
to integrins.
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Integrins are an ancient superfamily of heterodimeric
transmembrane proteins that are involved in diverse cell
processes, such as cell-cell adhesion and both inside-out and
outside-in cell signaling, at cell surfaces (Sebé-Pedrós et al.,
2010). The heterodimers consist of an alpha (a) and a beta (b)
subunit, of which there are as many as 18 a and eight b subunits
that form at least 24 heterodimeric structures known in humans
(Takada et al., 2007). Some integrins, such as aVb3, are
ubiquitously expressed across human tissues, while others are
specific to certain cell types, such as aIIbb3 to platelets (Etzioni,
1999). In total, integrins recognize a large variety of cell surface,
extracellular matrix, and soluble ligands (Takada et al., 2007).
The most frequently observed integrin-binding motif, RGD, is
present on several extracellular proteins, such as fibronectin and
vitronectin, and can interact with at least 12 integrin subtypes
(Ruoslahti, 1996). This motif uses the negatively-charged
aspartate to interact with positively-charged cations in the
metal ion–dependent adhesion site (MIDAS) domain of
integrins (Xiong et al., 2002). Other non-RGD motifs have
been discovered to be integrin-binding, such as the LDV
sequence from vascular cell adhesion molecule and the
GLOGER sequence (where O is hydroxyproline) from collagen
that bind a4 and a1b1 integrins, respectively (Makarem and
Humphries, 1991; Barczyk et al., 2010). Designed de novo
peptides and peptides homologous to natural ligands, such as
ATN-161 (Ac-PHSCN-NH2), have also been described to
recognize integrins and some do not share sequence identity or
similarity to known integrin-binding motifs (van Golen et al.,
2002; Cianfrocca et al., 2006). Thus, integrin-ligand specificity is
still incompletely understood and may involve interactions with
varying motifs that correspond to binding sites on different
domains of integrin dimers (Luo et al., 2007).
Because integrins are largely accessible on the surface of human
cells, they are a common target for cell entry by viral pathogens
(Maginnis, 2018). Surface proteins of some viruses, such as the
capsid protein VP1 of coxsackievirus A9, contain commonly
known integrin-binding sequences, such as RGD, that bind
integrins to gain entry into cells or modulate downstream
signaling pathways, while other viruses have acquired novel
integrin-binding mechanisms, for example the binding of
human echovirus 1 outside of the known ligand-binding site on
a2b1 integrin (Roivainen et al., 1994; Jokinen et al., 2010; Hussein
et al., 2015). Other viruses are known to bind integrins, such as
HIV-1 binding to a4b7, but the specific residues involved in the
interactions are still unknown (Liu and Lusso, 2020). Thus, further
investigation of the evolution of integrin-binding for viral
pathogens is important for a better understanding of viral cell
entry and cell signaling perturbations during infection.
The Severe Acute Syndrome Coronavirus 2 (SARS-CoV-2)
spike protein receptor-binding domain, which binds to
angiotensin-converting enzyme 2 (ACE2) to initiate viral cell
entry, has been shown to contain an exposed RGDmotif that has
been suggested to be integrin-binding, thus potentially allowing
for integrin-mediated cell entry (Luan et al., 2020; MakowskiFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 2et al., 2021). Experimental studies have shown that the SARS-
CoV-2 spike protein directly binds aVb3 and a5b1 integrins and
may also interact with a3, b1, a4, and aX integrin subunits
(Aguirre et al., 2020; Kotani and Nakano, 2020; Beddingfield
et al., 2021; Nader et al., 2021; Wang et al., 2021). RGD-based
drugs were found to inhibit spike binding to aVb3 and a5b1
integrins, and mutating the RGD motif to RGE or RGA was also
found to decrease binding to aVb5 integrins – further implicating
the spike RGD motif in interactions with integrins (Sebé-Pedrós
et al., 2010; Robles et al., 2021). Additionally, the canonical
SARS-CoV-2 cell entry receptor, ACE2, has been shown to
associate with a5b1 integrins, potentially facilitating virus
internalization (Beddingfield et al., 2021; Kliche et al., 2021). A
structure-based computational study has indicated that the RGD
motif accessibility to integrins depends based on its depth within
the spike receptor-binding domain (Othman et al., 2021). The
study performed protein-protein docking between the spike
protein and a5b1, aIIbb3, and aVb8 integrins and found that
the interactions were not favourable, thus suggesting that other
motifs on the spike receptor-binding domain may be involved in
interactions with integrins. Also, some of the integrins
discovered to be associated with SARS-CoV-2 cell entry, such
as aX, are not known to bind RGD peptides (Wang et al., 2021).
No definitive structural study has, yet, been described for spike-
integrin interactions. Thus, although the RGD sequence has been
shown as the probable integrin-binding motif for RGD-binding
integrins, the jury is still out on motifs on the spike protein that
allow binding to non-RGD-binding integrins or if other spike
motifs synergize with RGD-related binding to integrins.
The presence of non-RGD integrin-binding motifs on
coronavirus, particularly SARS-CoV-2, spike proteins has not
been systematically investigated. Herein, to infer potential
connections, we investigate integrins that have been
demonstrated to be directly involved in binding to the spike
protein, that have been shown to mediate viral entry through the
spike protein, or that exhibit changed expression over the course
of SARS-CoV-2 infection. Furthermore, we have utilized
sequence and structure-based bioinformatics approaches to
improve our understanding of the potential of spike binding to
integrins by cataloguing all known integrin-binding motifs and
mapping them to the SARS-CoV-2 spike protein receptor-binding
domain. Since the N-terminal receptor-binding domain of the
SARS-CoV-2 spike protein is heavily glycosylated, the C-terminal
receptor-binding domain – which contains the main interaction
site with ACE2 – was chosen for study. Amino acid sequence
alignments revealed that some exact and several similar matches
were discovered between known integrin-binding motifs and the
SARS-CoV-2 spike protein. Subsequent structural analyses reveal
that the three-dimensional availability of some motifs is greater
than that of the RGD sequence. The evolution of these motifs from
phylogenetically close betacoronaviruses, such as SARS-CoV and
RaTG13, was also analyzed alongside recently recorded mutations
in the SARS-CoV-2 spike protein. The combination of these ideas
suggests that integrin binding may also occur independently of the
RGD motif on the spike protein. Further experimental work is
necessary to validate potential spike-integrin interactions.November 2021 | Volume 11 | Article 765300
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Within the extensive research into SARS-CoV-2, several studies
have outlined changes in integrin expression and some have
shown direct interactions between the spike protein and different
integrins. Since increases in integrin expression may indicate
their potential usage as cell entry receptors by the spike protein,
as previously described with dengue virus serotype 2 and b3
integrins, a meta-analysis of expressed integrins during SARS-
CoV-2 infection may give insight into which corresponding
integrin-binding motifs may be of interest (Zhang et al., 2007;
Calver et al., 2021; Gisby et al., 2021).
Binding assays have shown that the spike protein directly
interacts with a5b1 and aVb3 integrins (Beddingfield et al., 2021;
Nader et al., 2021). One study discovered that the ATN-161
pentapeptide inhibited interactions between integrin a5b1 and
the SARS-CoV-2 spike protein, for which they predicted three
inhibitory ATN-161 binding sites on a5b1 (Beddingfield et al.,
2021). Cilengitide, an RGD-based drug, and an RGD peptide
were found to block the SARS-CoV-2 spike protein from binding
to aVb3 and a5b1 integrins, respectively, indicating that the spike
protein binds in an RGD-dependent manner (Nader et al., 2021;
Robles et al., 2021). A co-immunoprecipitation study found that
mutating the RGD sequence to RGE or RGA reduced the binding
of the SARS-CoV-2 spike protein to aVb5 integrins (Gao et al.,
2021). Binding assays demonstrated direct binding between the
spike protein and b1 integrins (Park et al., 2021). A screening of
candidate cell entry receptors for SARS-CoV-2 suggested that a3
and b1 integrins may be involved, and a CRISPR activation
screening looking at neuronal receptors involved in SARS-CoV-2
infection found that aX integrins may mediate cell entry (Kotani
and Nakano, 2020; Wang et al., 2021). The antibody
natalizumab, which binds to a4 integrins, was found to
decrease SARS-CoV-2 infection, hinting at the potential use of
these integrins in cell entry (Aguirre et al., 2020). These studies
provide more definitive proof that integrins interact with the
SARS-CoV-2 spike protein.
Reviewing changes in integrin expression during SARS-CoV-
2 infection may give clues about their potential roles as viral cell
entry receptors: increases in expression suggest potential usage,
while decreases in expression may rule out their involvement
(Fantini and Yahi, 2015). Notably, however, integrin expression
may also be an indicator of several other altered cellular
processes, such as inflammation and apoptosis, during
infection (Futosi et al., 2013). Furthermore, increased integrin
expression has also been shown to enhance viral replication
irrespective of binding to viral surface proteins, and decreased
expression may result as a viral mechanism to prevent multiple
viruses from infecting the same cell or as a defence mechanism by
the host (Michel et al., 2005; Lanier, 2008; Schmidt et al., 2013).
Integrins that showed increased expression were selected since
expression of the canonical SARS-CoV-2 entry receptor, ACE2,
has also been shown to increase following infection (Zamorano
Cuervo and Grandvaux, 2020). Three publicly-available
expression datasets from the Gene Expression Atlas collectively
showed that there were increases in a1, aV, and b1 integrinFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 3expression and decreases in a3, a4, aD, b4, and b7 integrin
expression post SARS-CoV-2 infection in colon cells and
increases in a2, a7, aM, aV, b2, and b8 integrin expression and
decreases in aD and b7 integrin expression in infected lung cells
(Supplementary Table 1) (Desai et al., 2020; Vanderheiden et al.,
2020; Wu et al., 2020). One study looked at longitudinal
proteomic profiles in SARS-CoV-2 patients and found that the
presence of b6 integrins increased over time while a11 integrins
decreased (Gisby et al., 2021). A mass cytometry screening of
transmembrane protein expression of platelets from SARS-CoV-2
patients found increased expression of aIIbb3 integrins
(Bongiovanni et al., 2021). These studies suggest that the
expression patterns of several integrin subtypes are influenced
by SARS-CoV-2 infection and that several are available as
potential receptors.
Altogether, the data suggest that a1, a2, a4, a7, aM, aV, aX, b1,
b2, b6, b8, a5b1, aVb3, and aIIbb3 integrins could be of use to the
SARS-CoV-2 spike protein. The a2, a4, a7, aV, b1, b6, b8, a5b1,
aVb3, and aIIbb3 integrins are all known to be RGD-binding (or
part of dimers that bind RGD for individual alpha or beta
subunits), while the a1, aM, aX, and b2 are not known to be
part of dimeric complexes that bind RGD sequences, which
suggests that spike could potentially interact with integrins using
motifs outside of the RGD sequence. Of note, the expression and
direct experimental studies have been limited by cell type, and
other integrin subtypes, such as aE and aL, have not been
extensively explored. Thus, an evaluation of potential non-
RGD integrin-binding motifs present on the SARS-CoV-2
spike protein may help guide further structural investigations
and may shed light on the integrin-binding potential of
other viruses.NON-RGD POTENTIAL INTEGRIN-BINDING
MOTIFS ON THE SARS-CoV-2 SPIKE
PROTEIN RECEPTOR-BINDING DOMAIN
The use of non-RGD integrin-binding motifs on the SARS-CoV-
2 spike protein has only been explored briefly: an LDI motif was
discovered on the outside of the C-terminal receptor-binding
domain (RBD) (Tresoldi et al., 2020). Thus, to expand the
understanding of potential non-RGD integrin-binding sites on
the SARS-CoV-2 protein, we gathered all known non-RGD
integrin-binding motifs and compared them to the sequence of
the SARS-CoV-2 RBD and further analyzed their structural
accessibility for potential binding to integrins. The RGD motif
was analyzed in parallel as a reference.
To collect all known integrin-binding motifs, we searched the
PepBank and ELM web servers using “integrin” and “integrin-
binding” search terms and selected all non-RGDmotifs that were
returned (Shtatland et al., 2007; Duchrow et al., 2009; Kumar
et al., 2020). We additionally performed a literature search to
include motifs from viruses and de novo or homology-derived
peptides not found in the database queries. The search resulted in
a total of 71 motifs found from ELM (6), PepBank (36), and the
literature search (29) (Supplementary Table 2).November 2021 | Volume 11 | Article 765300
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spike receptor-binding domain (residues 333-523) using
EMBOSS Needle and the EBLOSUM62 similarity matrix and
sequence identity and similarity were recorded (Madeira et al.,
2019). The reverse sequence of the integrin-binding motifs was
also screened against the RBD sequence, since DGR sequences
have been found to bind RGD-recognizing integrins (Spitaleri
et al., 2008). We focused on motifs that reported amino acid
similarity percentages above 50%, although manual inspection of
the alignments revealed some alignments that had similar but out
of order amino acids, which may still exhibit similar
physicochemical characteristics.
The sequence mapping resulted in 27 integrin-binding motifs
that align to 11 motifs on the SARS-CoV-2 spike RBD (Table 1
and Figure 1A). Except for RGD, only one motif, the LDS
sequence that binds a4b1 and a5b1 integrins, on the SARS-
CoV-2 spike RBD was found to match at 100% identity in the
forward direction; however, one motif read in the reverse
direction, TEI, was found to align at 100% identity to the [L,I]
ET motif that has been shown to bind aLb2 integrins. Using
amino acid similarity, the spike RKSNLK motif aligned at 100%
similarity to the a3b1-binding N[G,V]R and aVb6-binding
QRSDL motifs. In the reverse direction, the aIIbb3-binding
VPW motif and the YGL motif, which binds a4b1, a4b7, a9b1
integrins, were found to be 100% similar to the spike FPL and
VGY motifs, respectively. Several aVb6-binding motifs –
RTDLY, REDV, ASDIS, RTDLS, RDLET – were found to beFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 4between 50.0% and 66.6% similar to the ERDIS motif on the
spike protein, which just precedes the TEI sequence. The spike
MLD motif, which binds a4b1, a9b1, a7b4 integrins, was also
found to have 66.6% identity to the aforementioned LDS motif.
The a1b1-binding (R/K)TS motif was found to be 66.6% similar
to the previously mentioned RKSNLK motif. The aVb3-binding
GRKRK and GRFPF motifs were found to be 60% similar to the
NRKRI and GYQPY (overlapping the previously mentioned
VGY motif) spike motifs. The LLG motif, which has been
shown to bind b2 integrins, was found to be 60% similar to
both the VGG and GVG motifs on the spike RBD. Interestingly,
the ATN-161 pentapeptide (Ac-PHSCN-NH(2)) was discovered
to be 42.9% identical to the spike RBD STPCN motif, while the
aXb2-binding GPRP motif also aligned at 50% similarity to the
overlapping GSTP spike motif. The G[F,L,V][P,O]GE[N,R]
motifs, which have been shown to bind a1b1 and a2b1
integrins, were found to be ~ 50% similar to the spike
GVEGFN motif. The spike YGF motif was found to be 66.6%
similar to the YGL motif. Altogether, these motifs comprise the
potential for the spike protein to bind 12 integrin subtypes
independent of the RGD sequence.
The presence of motifs on the SARS-CoV-2 spike protein that
are 100% identical or similar to integrin-binding motifs brings
attention to the potential for binding to integrins independent of
the RGD sequence. Some of the spike motifs, such as GVG and
VGY, are overlapping, which may induce stronger binding or











403-405 RGD RGD 100/100 a5b1,a8b1,aVb1,aVb3, aVb5, aVb6, aVb8,
aIIbb3, (a2b1), (a3b1), (a4b1), (a4b7), (a7b1)
354-358 NRKRI GRKRK 60/60 aVb3
444-447/502-504 KVGG/GVG LLG 33.3/66.6 b2
457-462 RKSNLK N[G,V]R 33.3/100 a3b1
(R/K)TS 66.6/66.6 a1b1
QRSDL 40/100 aVb6






476-482 GSTPCN PHSCN 42.9/42.9 a5b1,aVb1,aVb3
GPRP 50/50 aXb2
490-492 FPL YGL 33.3/66.6 a4b1,a4b7,a9b1
VPW 33.3/33.3 (33.3/100) aIIbb3
503-505 VGY YGL 33.3/33.3 (66.6/100) a4b1,a4b7,a9b1
VPW 33.3/66.6 aIIbb3











441-445 LDS IDS/LDV 100/100 a4b1,(a5b1)
MLD 66.6/66.6 a4b1,a9b1,a7b4
482-487 GVEGFN GFPGER/GLOGEN 50/50 a1b1,a2b1
496-498 YGF YGL 66.6/66.6 a4b1,a4b7,a9b1
504-508 GYQPY GRFPF 40/60 aVb3November 2021 | Volume 11 | Article 765300
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integrin-binding motifs but the amino acids were out of order.
For example, the spike ERDI motif was found to be 50% similar
to the aVb6-binding REDV motif by alignment of the D and I/V
residues, but the E and R residues were found on both motifs in a
different order. This was also the case for the similarity between
the ATN-161 pentapeptide sequence (PHSCN) and the spike
STPCN motif, in which both the P and S residues are present but
in a different order. Furthermore, the similarity to the ATN-161
pentapeptide is interesting considering studies that suggest its
protective ability against SARS-CoV-2 infection, although the
peptide has been suggested to also bind the RGD-binding site on
integrins (Amruta et al., 2021; Beddingfield et al., 2021).
Structural analysis to investigate the accessibility of the motifs
on the spike protein may lend more insights into their potential
ability to bind integrins.STRUCTURAL ORIENTATION OF
POTENTIAL INTEGRIN-BINDING MOTIFS
The alignments and the amino acid configurations of the
corresponding spike protein motifs were subsequently
inspected on the structure of the spike protein RBD [3D modelFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 5generated as previously described (Beaudoin et al., 2021)] to
determine whether the side chains are found on the surface of the
receptor-binding domain. Since the literature on the 3D
structure of binding sites for non-RGD motifs is limited and
the potential binding modes may be numerous, in order to
quantitatively assess motif accessibility, structural flexibility
and solvent accessibility were determined to better understand
the surrounding residue microenvironment. Ten 3D models
representing different points in flexibility for the SARS-CoV-2
RBD were generated using CABS-Flex 2.0, which utilizes
molecular dynamics to infer root mean squared flexibility
(RMSF) for each residue, and the solvent accessibility (defined
as the number of water molecules in contact with the residue *
10) for each residue in each model was calculated using DSSP
(Table 2; Supplementary Table 3) (Kabsch and Sander, 1983;
Kuriata et al., 2018). Overall, as discussed in several studies, the
SARS-CoV-2 RBD does not exhibit extensive flexibility, but the
distal ends of the ACE2 binding motif in particular, which are
often unresolved in crystal structures, were reported with the
highest flexibility (~ 6 RMSF) (Dehury et al., 2020; Spinello et al.,
2020). The mean RMSF for all residues of interest was 1.84, and
the average solvent accessibility was 65.70.
After structural analysis, 19 integrin-binding motifs that
cover 8 motifs on the spike RBD were found as potentiallyA
B
C
FIGURE 1 | Putative integrin-binding motifs on the SARS-CoV-2 receptor-binding domain.The SARS-CoV-2 receptor-binding domain (RBD) amino acid sequence is
shown with the putative integrin-binding motifs marked in red (A). The SARS-CoV-2 spike RBD is depicted with the predicted structurally-accessible integrin-binding
motifs highlighted in different colors (B). The spike RBD is shown aligned with the PDB: 6m0j structure in order to show the potential accessibility of these motifs
when the spike protein is bound to the canonical host cell entry receptor ACE2 (green) (B). A sequence alignment of the putative integrin-binding motifs found on the
SARS-CoV-2 receptor binding domain with spike sequences from the SARS-CoV, RatG13, MERS-CoV, Pan-CoV-GD, Pan-CoV-GX-P4L, Pan-CoV-GX-P2V, SL-
CoVZC45, BtKY72 betacoronavirus strains is shown with a corresponding phylogenetic tree of the coronavirus genomes generated using FastTree 2.1 and
visualized with iTOL (C).November 2021 | Volume 11 | Article 765300
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were discarded due to their buriedness or incompatibility with
potential binding to integrins based on the knowledge of the
original integrin-motif interactions (Figure 1B). The STPCN
and GVEGFN motifs, which are found adjacent to each other in
sequence, exhibited the highest flexibility with an average of 4.43
and 4.48 RMSF, respectively, and high average solvent
accessibility of 72.36 and 82.57, respectively. However, after
noting that the GVEGFN motif is 1) missing a crucial
glutamate between the glycine and asparagine residues and
2) that recent mutation E484K exchanges the remaining acidic
glutamate for a basic lysine, this motif was deemed unlikely to
mimic integrin-binding in the manner that has been shown for
natural G[F,L,V][P,O]GE[N,R] ligands (Hamaia et al., 2012;
Wise, 2021). Thus, GVEGFN was discarded. The KVGG motif
reported the next highest combined flexibility and solvent
accessibility at 2.06 RMSF and 76.29, respectively. The GVG
motif, which sits directly in front of the RGD motif, also
exhibited a high mean RMSF (2.94) and a solvent accessibility
of 66.76. The RKSNLK and ERDISTEI reported average RMSF
values of 1.60 and 1.23, respectively, and solvent accessibility
values of 71.71 and 70.41, respectively. The overlapping GVG,
VGY, and GYQPY motifs exhibited RMSF values of 2.94, 1.90,
0.83, respectively, and solvent accessibility values of 66.76, 75.21,
47.62. Because of the low flexibility and solvent accessibility of
residues in the GYQPY motif, it was discarded as potentially
integrin-binding. The LDS motif was found to exhibit low
flexibility (1.04 RMSF) and the lowest average solvent
accessibility of all putative motifs at 30.61. Because the
aspartate residue, which is important for binding in the
MIDAS region of integrins, in the LDS motif was buried inside
the RBD (solvent accessibility of D: 3.53), the LDS motif was
discarded (Ruoslahti, 1996). The FPL motif exhibited a low
average flexibility at 0.571 RMSF but a mean solvent
accessibility (63.18) close to the average of other motifs. The
NRKRI motif reported the second-lowest average flexibility (0.47
RMSF) but the highest average solvent accessibility of 82.78. The
YGF motif showed the lowest mean flexibility (0.42 RMSF) and
solvent accessibility (25.27) and was, thus, discarded.
Although the RGD motif was described as inaccessible for
integrin-binding by previous computational analyses, the R and
D residues were found to exhibit low flexibility overall – 0.244
and 1.015 RMSF, respectively – but high average solvent
accessibility – 49.09 and 87.27, respectively. The RGD motif
reported an average 0.585 RMSF and a solvent accessibility of
46.85. The reference model showed low solvent accessibility for
the arginine and aspartate residues (R: 24 and D: 27), which
could imply that small conformational changes may have largeTABLE 2 | Root mean square flexibility (RMSF) and average solvent accessibility
(SA) values for the putative integrin-binding motifs on the SARS-CoV-2 spike
protein receptor-binding domain.
Residue # Residue RMSF Average SA
354 N 0.31 63.18
355 R 0.50 119.18
356 K 0.46 62.27
357 R 0.43 162.45
358 I 0.66 6.82
Average 0.47 82.78
403 R 0.24 49.09
404 G 0.50 4.18
405 D 1.02 87.27
Average 0.59 46.85
441 L 1.15 74.00
442 D 0.90 3.18
443 S 1.06 14.64
Average 1.04 30.61
444 K 1.42 154.45
445 V 2.44 61.55
446 G 2.68 42.73
447 G 1.72 46.45
Average 2.06 76.30
457 R 0.92 110.73
458 K 1.40 46.91
459 S 1.79 59.45
460 N 1.77 89.82
461 L 1.70 17.00
462 K 2.04 106.36
Average 1.60 71.71
465 E 1.37 73.64
466 R 0.72 65.09
467 D 1.61 77.64
468 I 1.05 89.82
469 S 1.18 32.27
470 T 1.20 83.55
471 E 1.12 58.45
472 I 1.58 82.82
Average 1.23 70.41
477 S 3.78 66.45
478 T 3.46 32.09
479 P 4.31 67.09
480 C 5.21 85.73
481 N 5.38 110.45
Average 4.43 72.36
482 G 5.92 57.36
483 V 5.48 91.36
484 E 5.24 131.27
485 G 4.54 59.82
486 F 3.38 122.55
487 N 2.61 94.27
Average 4.48 82.57
490 F 0.75 75.09
491 P 0.57 39.64
492 L 0.40 74.82
Average 0.57 63.18
495 Y 0.45 15.55
496 G 0.45 21.73
497 F 0.37 38.55
Average 0.42 25.27
502 G 3.99 78.09
503 V 2.80 72.45
504 G 2.05 49.73
505 Y 0.85 103.45
506 Q 0.61 67.91
(Continued)TABLE 2 | Continued
Residue # Residue RMSF Average SA
507 P 0.42 1.09
508 Y 0.21 15.91
Average (GVG) 2.94 66.76
Average (VGY) 1.90 75.21
Average (VGYQPY) 0.83 47.62November 2021 | Volume 11 | Article 765300
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front of the RGD motif in 3D space showed high flexibility (2.94
RMSF), which may allow for restructuring to accommodate
potential RGD-based interactions.
The resulting motifs comprise the potential binding to b2,
a1b1, a3b1, a4b1, a4b7, a9b1, aVb1, aVb3, aVb6, aLb2, aXb2, and
aIIbb3 integrins. Interestingly, several of these integrins overlap
those that were suggested to directly interact with the spike
protein or exhibit increased expression during SARS-CoV-2
infection: a1, a4 aV, aX, b1, b2, b6, aVb3, aIIbb3. Since many of
the integrins overlap RGD-binding integrins, perhaps the
putative non-RGD motifs on the spike protein may provide
synergistic binding with the RGD sequence. The RGD motif is
overall less accessible than some of the newly discovered
potential integrin-binding motifs, such as STPCN and
ERDISTEI, although the changes in solvent accessibility due to
small conformational changes may have a significant impact on
potential integrin-binding. Given that, however, several other
motifs, such as the RKSNLK, VGY, and NRKRI, have strong
potential for binding to integrins based on amino acid identity
and similarity and 3D availability. Further experimental work is
needed to validate these potential interactions.EVOLUTION OF PUTATIVE NON-RGD
INTEGRIN-BINDING MOTIFS
As previously mentioned, the evolution of integrin-binding
motifs on viral surface proteins provides another route for
potential host cell entry. Thus, a look at the conservation of
these motifs in related betacoronaviruses and an inspection of
recently recorded mutations in the SARS-CoV-2 spike RBD may
provide insights into the relevance of these motifs.
Recent genomic comparisons between the spike sequence of
SARS-CoV-2 and other coronaviruses have shown that the
receptor-binding domain is under both purifying and positive
selection (Berrio et al., 2020; Li et al., 2020). Mutations have been
suggested to increase affinity for ACE2 or to prevent recognition
by neutralizing antibodies (Armijos-Jaramillo et al., 2020;
Greaney et al., 2021). As shown in Figure 1C, an alignment of
the SARS-CoV-2 spike receptor-binding domain sequence
(NCBI Accession: NC_045512) with the sequences of the
SARS-CoV (NC_004718); bat coronavirus strains RaTG13
(MN996532), SL-CoVZC45 (MG772933), and BtKY72
(KY352407); pangolin coronavirus strains GD (MT121216),
GX-P4L (MT040333), and GX-P2V (MT072864); and the
more phylogenetically distant MERS-CoV (NC_019843) shows
that some of the motifs are completely conserved among recently
diverged viruses while others have evolved more recently (Price
et al., 2010; Letunic and Bork, 2021). Notably, only the pangolin
GD strain was to share 100% amino acid sequence identity with
all of the potential integrin-binding motifs, including the RGD
sequence, from SARS-CoV-2 (Liu et al., 2020). The pangolin
strain RGD sequence has not yet been mentioned in the
literature, and its presence reveals that integrin-binding motifsFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 7may evolve before zoonotic transmission to humans. Some of the
motifs, such as ERDISTEI and NRKRI, are completely conserved
among the RaTG13 and pangolin coronavirus strains, while
other motifs, such as RKSNLK and STPCN, seem to have
evolved more recently. The alignments support studies that
suggest that SARS-CoV-2 is a result of recombination between
human, pangolin, and bat coronaviruses (Li et al., 2020). In
addition to the analysis of the integrin-binding potential of these
motifs, these insights can provide clues towards SARS-CoV-2
spike evolution.
Interestingly, the recent SARS-CoV-2 spike mutations seem
to only directly affect the STPCN motif – where the G476S
mutation adds another serine just before the serine already
present and the S477N and T478K mutations affect the
sequence itself (Guruprasad, 2021). Notably, the T478K
mutation found in the Delta strain would create a more similar
sequence to the aligned ATN-161 (PHSCN) sequence by
replacing the polar threonine with a basic lysine, which may
mimic basic histidine interactions (Aoki et al., 2021). The lack of
mutations near or on the other putative integrin-binding sites,
especially considering the conservation with the pangolin
coronavirus genome, may give credibility to their integrin-
binding potential.
The combination of 1) the conservation among recent
betacoronaviruses and 2) the lack of mutations or insertion of
mutations that provide better alignments for the putative integrin-
binding motifs on the SARS-CoV-2 protein reveals that these sites
may, indeed, be involved in interactions with integrins.DISCUSSION
The SARS-CoV-2 spike protein has been shown to bind multiple
integrin subtypes. Although there is growing evidence for
interactions based on the spike RGD sequence, the exact
binding mechanisms are still unknown (Robles et al., 2021;
Simons et al., 2021). Additionally, previous preliminary
computational studies suggest that the spike RGD motif is not
completely accessible for integrin-binding, while there have also
been other non-RGD-binding integrins that have been suggested
to be potentially involved in SARS-CoV-2 viral entry (Othman
et al., 2021; Wang et al., 2021). An analysis of putative non-RGD
integrin-binding motifs on the SARS-CoV-2 receptor-binding
domain identified several viable candidates after sequence
alignment and subsequent structural characterization. The
motifs comprise potential binding to RGD-binding integrins,
such as aVb6, as well as non-RGD-binding integrins, such as
aXb2. A meta-analysis of reported integrin expression levels
revealed that several of the putative spike-binding partners are
increased during SARS-CoV-2 infection, further adding to their
validity. Since aX integrins were both found as putative cell entry
receptors for the SARS-CoV-2 spike protein in a CRISPR
activation screen, the results presented in this study may help
unravel potential binding mechanisms (Wang et al., 2021). The
identified motifs may act together with the RGD motif orNovember 2021 | Volume 11 | Article 765300
Beaudoin et al. SARS-CoV-2 Spike Protein and Integrinsindependently to bind integrins for cell entry or to interfere with
cell signaling pathways.
Of interest, one motif was found to be similar to the ATN-161
pentapeptide, which has been shown to block against SARS-
CoV-2 infection in vivo (Amruta et al., 2021). The RGD-based
drug, Cilengitide, and the RGD peptide were also found to
inhibit spike-integrins interactions on endothelial cells (Nader
et al., 2021; Robles et al., 2021). Such studies highlight that
inhibiting spike-integrin interactions may be useful in blocking
or ameliorating infection. Gao et al. also suggested that
administering entire integrin subunits could be helpful as a
treatment option (Gao et al., 2021). Thus, additional work to
define potential non-RGD-based integrin interactions may give
rise to new drug target options. Experimental elucidation of the
binding mechanisms and affinities between the SARS-CoV-2
spike protein and the diverse integrin dimers would be helpful
for engineering inhibitory peptides or small molecules.
As ACE2 has been shown to associate with certain integrin
subtypes, such as a2, a5 and b1, it is possible that integrin-
binding motifs on the SARS-CoV-2 receptor-binding domain
may be exposed even after binding with ACE2, which may then
allow subsequent interaction between the spike-ACE2 complex
and an integrin on the same receptor-binding domain (Clarke
et al., 2012). However, since the coronavirus spike protein
oligomerizes to its final trimeric form and, thus, contains three
receptor-binding domains (one per protomer), the spike protein
may interact with integrins in a variety of ways: the SARS-CoV-2
spike protein may 1) bind integrins independently of ACE2, 2)
bind to ACE2 and then bind an integrin using another receptor-
binding domain (or vice-versa) either on the same or a different
spike protein, or 3) bind to ACE2, first, and then utilize accessible
motifs to bind an integrin from the same spike receptor-binding
domain (Makowski et al., 2021).
Evolutionary sequence comparisons between different
coronavirus strains revealed that some of the putative integrin-
binding motifs have recently emerged while others are more
conserved among betacoronaviruses. Notably, all of the potential
integrin-binding motifs, including the RGD sequence, were
conserved in one pangolin coronavirus strain, which suggests
that integrin-binding motifs may evolve before zoonotic transfer
to humans. The presence of these motifs alongside the RGD
motif on the pangolin coronavirus genome further supports their
potential as mediators for integrin-binding. The discovery that
the evolution of the RGD and other putative non-RGD integrin-
binding motifs on the spike protein preludes the jump to humans
reveals that the integrin-binding motifs may be a driving factor
for adapting to human cells. These results indicate that the
mapping of all known integrin-binding sequences to viral
surface proteins may help to better understand the evolution of
integrin use among viruses. Recorded mutations relevant to the
putative integrin-binding motifs were centred around one motif
similar to the ATN-161 pentapeptide, in particular, which might
increase potential affinity to integrins. Monitoring future
mutations on the spike protein receptor-binding domain may
be useful to identify new cell entry receptors. Subsequent
investigation into the connections between spontaneousFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 8integrin-binding motif generation and viral transmission
between species may further delineate the role of integrins in
zoonotic transfer.
The discovery of potential integrin-binding motifs
independent of the RGD sequence on the SARS-CoV-2 spike
protein highlights that integrin-binding motifs on viral surface
proteins may be more widespread than previously established.
Since integrins are ubiquitously expressed throughout the
human body, their usage as receptors for cell entry by viruses
should be scrutinized. The RGD and other putative integrin-
binding motifs on the spike protein surface provide potential
mechanisms through which SARS-CoV-2 may utilize integrins
as cell entry receptors or to interfere with host signaling
pathways. Further experimental work is necessary to validate
the direct structural interactions between the SARS-CoV-2 spike
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